EGFR and head and neck squamous cell carcinoma: Since about 90% of HNSCC has EGFR overexpression [26], to test whether hDT806 exhibits efficacy against human HNSCC, we evaluated the effects of hDT806 on the viability and proliferation of four HNSCC cell lines: JHU-011, -013, -022, and -029 cells.